Literature DB >> 12799780

Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort.

Kristiina Moilanen1, Juha Veijola, Kristian Läksy, Taru Mäkikyrö, Jouko Miettunen, Liisa Kantojärvi, Pirkko Kokkonen, Juha T Karvonen, Anne Herva, Matti Joukamaa, Marjo-Riitta Järvelin, Juha Moring, Peter B Jones, Matti Isohanni.   

Abstract

BACKGROUND: The diagnosis of schizophrenia by clinicians is not always accurate in terms of operational diagnostic criteria despite the fact that these diagnoses form the basis of case registers and routine statistics. This poses a challenge to psychiatric research. We studied the reasons for diagnostic discordance between clinicians and researchers.
METHODS: The Northern Finland 1966 Birth Cohort (n = 11,017) was followed from mid-gestation to the end of the 31st year. Psychiatric outcome was ascertained through linkage to the national hospital discharge register containing clinical diagnoses made by the attending physician. The hospital notes of all subjects admitted to hospital during the period 1982-1997 due to psychiatric disorder were reviewed and 475 research, operational DSM-III-R diagnoses were formulated.
RESULTS: Ninety-six cases met operational criteria for schizophrenia. Fifty-five (57 %) had concordant diagnoses: both the clinical and research diagnoses were schizophrenia. Forty-one (43 %) had discordant diagnoses: the clinical diagnosis was other than schizophrenia (mainly schizophreniform or other psychosis). Discordant cases were more likely to be older at onset, experience a shorter treatment duration, fewer treatment episodes, and to have a comorbid diagnosis mental retardation.
CONCLUSIONS: Clinicians do not make the diagnosis of schizophrenia as often as the application of operational criteria would suggest they should. The discordance between clinical diagnosis and the research, operational diagnosis is especially likely in cases having late onset and few contacts to psychiatric hospital.

Entities:  

Mesh:

Year:  2003        PMID: 12799780     DOI: 10.1007/s00127-003-0638-z

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  30 in total

1.  Advanced paternal age and parental history of schizophrenia.

Authors:  Brian Miller; Jaana Suvisaari; Jouko Miettunen; Marjo-Riitta Järvelin; Jari Haukka; Antti Tanskanen; Jouko Lönnqvist; Matti Isohanni; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2011-09-19       Impact factor: 4.939

2.  Is initiation of smoking associated with the prodromal phase of schizophrenia?

Authors:  Kaisa Riala; Helinä Hakko; Matti Isohanni; Anneli Pouta; Pirkko Räsänen
Journal:  J Psychiatry Neurosci       Date:  2005-01       Impact factor: 6.186

3.  Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study.

Authors:  Matti Isohanni; Jouko Miettunen; Pirjo Mäki; Graham K Murray; Khanum Ridler; Erika Lauronen; Kristiina Moilanen; Antti Alaräisänen; Marianne Haapea; Irene Isohanni; Elena Ivleva; Carol Tamminga; John McGrath; Hannu Koponen
Journal:  World Psychiatry       Date:  2006-10       Impact factor: 49.548

4.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

5.  Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L.

Authors:  Mark Weiser; Kyra Kanyas; Dolores Malaspina; Philip D Harvey; Ittai Glick; Deborah Goetz; Osnat Karni; Avi Yakir; Neil Turetsky; Shmuel Fennig; Daniella Nahon; Bernard Lerer; Michael Davidson
Journal:  Compr Psychiatry       Date:  2005 Jan-Feb       Impact factor: 3.735

6.  Phenotype mining in CNV carriers from a population cohort.

Authors:  Olli P H Pietiläinen; Karola Rehnström; Eveliina Jakkula; Susan K Service; Eliza Congdon; Carola Tilgmann; Anna-Liisa Hartikainen; Anja Taanila; Ulla Heikura; Tiina Paunio; Samuli Ripatti; Marjo-Riitta Jarvelin; Matti Isohanni; Chiara Sabatti; Aarno Palotie; Nelson B Freimer; Leena Peltonen
Journal:  Hum Mol Genet       Date:  2011-04-19       Impact factor: 6.150

7.  Prevalence and diagnosis of schizophrenia based on register, case record and interview data in an isolated Finnish birth cohort born 1940-1969.

Authors:  Ritva Arajärvi; Jaana Suvisaari; Jaana Suokas; Marjut Schreck; Jari Haukka; Jukka Hintikka; Timo Partonen; Jouko Lönnqvist
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09-27       Impact factor: 4.328

8.  Where have all the women gone?: participant gender in epidemiological and non-epidemiological research of schizophrenia.

Authors:  Julia Longenecker; Jamie Genderson; Dwight Dickinson; James Malley; Brita Elvevåg; Daniel R Weinberger; James Gold
Journal:  Schizophr Res       Date:  2010-06       Impact factor: 4.939

9.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

10.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.